These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31451949)

  • 1. Assessing the Utility of In Vitro Screening Tools for Predicting Bio-Performance of Oral Peptide Delivery.
    Gadgil P; Alleyne C; Feng KI; Hu M; Gindy M; Buevich AV; Fauty S; Salituro G; Wen J; Li Y; Nofsinger R; Sawyer TK; Buist N
    Pharm Res; 2019 Aug; 36(10):151. PubMed ID: 31451949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin.
    Kristin F; René H; Boontida M; Buraphacheep JV; Maximilian A; Johanna M; Peter L
    Eur J Pharm Sci; 2017 Apr; 101():211-219. PubMed ID: 28179133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
    Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
    Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies.
    McCartney F; Jannin V; Chevrier S; Boulghobra H; Hristov DR; Ritter N; Miolane C; Chavant Y; Demarne F; Brayden DJ
    J Control Release; 2019 Sep; 310():115-126. PubMed ID: 31401199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labrasol
    Heade J; Maher S; Bleiel SB; Brayden DJ
    J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across Permeapad
    Ilie AR; Griffin BT; Brandl M; Bauer-Brandl A; Jacobsen AC; Vertzoni M; Kuentz M; Kolakovic R; Holm R
    Eur J Pharm Sci; 2020 Sep; 152():105452. PubMed ID: 32622980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
    Ghassemi S; Haeri A; Shahhosseini S; Dadashzadeh S
    AAPS PharmSciTech; 2018 Oct; 19(7):2961-2970. PubMed ID: 30030724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.
    Nekkanti V; Rueda J; Wang Z; Betageri GV
    Int J Pharm; 2016 May; 505(1-2):79-88. PubMed ID: 27041124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions.
    Roos C; Dahlgren D; Sjögren E; Sjöblom M; Hedeland M; Lennernäs H
    Eur J Pharm Biopharm; 2019 Sep; 142():387-395. PubMed ID: 31306752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses.
    Chow EC; Talattof A; Tsakalozou E; Fan J; Zhao L; Zhang X
    AAPS J; 2016 Nov; 18(6):1500-1511. PubMed ID: 27520379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.
    Ribadeneira MD; Aungst BJ; Eyermann CJ; Huang SM
    Pharm Res; 1996 Feb; 13(2):227-33. PubMed ID: 8932441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ameliorated Pharmacokinetics of VP-16 in Wistar Rats: A Possible Role of P-Glycoprotein Inhibition by Pharmaceutical Excipients.
    Akhtar N; Ahad A; Khan MF; Allaham A; Talegaonkar S
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):191-199. PubMed ID: 27016067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray freeze drying with polyvinylpyrrolidone and sodium caprate for improved dissolution and oral bioavailability of oleanolic acid, a BCS Class IV compound.
    Tong HH; Du Z; Wang GN; Chan HM; Chang Q; Lai LC; Chow AH; Zheng Y
    Int J Pharm; 2011 Feb; 404(1-2):148-58. PubMed ID: 21094233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
    Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
    Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of two in vitro methods for assessing drug absorption: Sartorius SM 16750 apparatus versus Everted Gut Sac.
    Lassoued MA; Khemiss F; Sfar S
    J Pharm Pharm Sci; 2011; 14(1):117-27. PubMed ID: 21501558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions.
    Zhou J; Zhou M; Yang FF; Liu CY; Pan RL; Chang Q; Liu XM; Liao YH
    Mol Pharm; 2015 Apr; 12(4):1084-95. PubMed ID: 25723098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.
    Nakate T; Yoshida H; Ohike A; Tokunaga Y; Ibuki R; Kawashima Y
    Eur J Pharm Biopharm; 2003 Mar; 55(2):147-54. PubMed ID: 12637090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.